Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-24 00:57 | 2023-08-21 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Officer; Chief Development Officer | Pharmaceutical Preparations | SALE | $16.66 | 1,490 | $24,817 | 26,962 | -5.2% |
| 2022-12-20 01:01 | 2022-12-16 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Officer; Chief Development Officer | Pharmaceutical Preparations | OPT+S | $19.49 | 2,212 | $43,116 | 26,821 | -7.6% |
| 2022-12-15 00:08 | 2022-12-12 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Officer; Chief Development Officer | Pharmaceutical Preparations | OPT+S | $18.26 | 19,711 | $359,972 | 26,821 | -42.4% |
| 2022-12-09 00:06 | 2022-12-07 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Officer; Chief Development Officer | Pharmaceutical Preparations | SALE | $16.47 | 494 | $8,136 | 26,821 | -1.8% |
| 2022-11-22 00:08 | 2022-11-17 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Officer; Chief Development Officer | Pharmaceutical Preparations | OPT+S | $15.85 | 3,289 | $52,128 | 27,315 | -10.7% |
| 2022-11-11 00:04 | 2022-11-09 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Officer; Chief Development Officer | Pharmaceutical Preparations | SALE | $16.54 | 494 | $8,171 | 27,315 | -1.8% |
| 2022-10-20 23:37 | 2022-10-18 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Officer; Chief Development Officer | Pharmaceutical Preparations | OPT+S | $19.41 | 8,590 | $166,735 | 27,809 | -23.6% |
| 2022-10-06 23:04 | 2022-10-05 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Officer; Chief Development Officer | Pharmaceutical Preparations | SALE | $21.64 | 988 | $21,380 | 27,809 | -3.4% |
| 2022-09-22 23:06 | 2022-09-20 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Officer; Chief Development Officer | Pharmaceutical Preparations | OPT+S | $20.72 | 16,840 | $348,943 | 28,797 | -36.9% |
| 2022-09-08 23:41 | 2022-09-07 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Officer; Chief Development Officer | Pharmaceutical Preparations | SALE | $18.63 | 988 | $18,406 | 28,797 | -3.3% |
| 2022-08-23 23:15 | 2022-08-19 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Officer; Chief Development Officer | Pharmaceutical Preparations | OPT+S | $19.13 | 8,539 | $163,389 | 29,785 | -22.3% |
| 2022-08-04 23:07 | 2022-08-03 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Officer; Chief Development Officer | Pharmaceutical Preparations | SALE | $16.81 | 988 | $16,608 | 17,285 | -5.4% |
| 2022-07-20 23:08 | 2022-07-19 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Officer; Chief Development Officer | Pharmaceutical Preparations | OPT+S | $16.01 | 11,444 | $183,271 | 18,273 | -38.5% |
| 2022-07-15 23:41 | 2022-07-14 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Officer; Chief Development Officer | Pharmaceutical Preparations | OPT+S | $15.14 | 9,104 | $137,864 | 18,273 | -33.3% |
| 2022-07-11 23:04 | 2022-07-07 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Officer; Chief Development Officer | Pharmaceutical Preparations | OPT+S | $15.05 | 9,666 | $145,453 | 21,023 | -31.5% |
| 2022-06-24 01:49 | 2022-06-22 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Officer; Chief Development Officer | Pharmaceutical Preparations | OPT+S | $15.01 | 1,545 | $23,198 | 23,688 | -6.1% |
| 2022-06-22 03:16 | 2022-06-17 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Officer; Chief Development Officer | Pharmaceutical Preparations | OPT+S | $15.04 | 5,887 | $88,565 | 23,994 | -19.7% |
| 2022-06-02 23:06 | 2022-05-31 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Officer; Chief Development Officer | Pharmaceutical Preparations | OPT+S | $15.22 | 400 | $6,086 | 25,194 | -1.6% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.